Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.17
-0.04 (-0.77%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Foghorn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
303305262272267848
Upgrade
Market Cap Growth
68.95%16.38%-3.64%2.10%-68.56%17.59%
Upgrade
Enterprise Value
1861483459-54807
Upgrade
Last Close Price
5.185.404.726.456.3822.87
Upgrade
PS Ratio
9.849.8811.617.9713.87643.15
Upgrade
PB Ratio
--2.81-5.76-3.532381.228.76
Upgrade
P/TBV Ratio
----2381.228.76
Upgrade
P/FCF Ratio
----1.39-
Upgrade
P/OCF Ratio
----1.38-
Upgrade
EV/Sales Ratio
6.034.781.511.74-612.13
Upgrade
Debt / Equity Ratio
-0.38-0.38-0.82-0.58459.880.60
Upgrade
Debt / FCF Ratio
----0.27-
Upgrade
Net Debt / Equity Ratio
1.081.084.542.45-2627.60-0.99
Upgrade
Net Debt / EBITDA Ratio
1.491.492.131.812.590.98
Upgrade
Net Debt / FCF Ratio
1.371.372.041.58-1.531.79
Upgrade
Asset Turnover
0.130.130.080.100.040.00
Upgrade
Quick Ratio
2.662.663.644.016.269.33
Upgrade
Current Ratio
2.732.733.734.116.379.44
Upgrade
Return on Equity (ROE)
-----224.54%-83.37%
Upgrade
Return on Assets (ROA)
-21.29%-21.29%-22.00%-19.53%-15.83%-16.24%
Upgrade
Return on Capital Employed (ROCE)
-59.30%-59.30%-46.20%-47.40%-33.50%-21.40%
Upgrade
Earnings Yield
-24.43%-24.32%-33.01%-36.15%-40.83%-11.94%
Upgrade
FCF Yield
-28.33%-28.21%-38.61%-43.82%72.14%-6.31%
Upgrade
Buyback Yield / Dilution
-14.72%-14.72%-30.79%-0.92%-11.89%-236.49%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.